歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Others > Sincalide

瀏覽歷史

S80567

Sincalide

源葉(MedMol) 99%
  • 英文名:
  • Sincalide
  • 別名:
  • 辛卡利特;氯縮膽囊素八肽;醋酸辛卡利特;H-ASP-TYR(SO3H)-MET-GLY-TRP-MET-ASP-PHE-NH2;H-ASP-TYR(SO3H)-MET-GLY-TRP-MET-ASP-PHE-NH2 AMMONIUM SALT;CHOLECYSTOKININ [TYR(SO3H)27]-FRAGMENT 26-33 AMIDE;CHOLECYSTOKININ, OCTAPEPTID
  • CAS號(hào):
  • 25126-32-3
  • 分子式:
  • C49H62N10O16S3
  • 分子量:
  • 1143.27
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車...
源葉(MedMol) S80567-1mg 99% ¥380.00元 5 - - - EA 加入購(gòu)物車
源葉(MedMol) S80567-5mg 99% ¥790.00元 7 - - - EA 加入購(gòu)物車
源葉(MedMol) S80567-25mg 99% ¥2750.00元 6 - - - EA 加入購(gòu)物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書。
  • 產(chǎn)品描述: Sincalide (Cholecystokinin octapeptide, CCK‐8) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. CCK‐8 is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. CCK‐8 can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. CCK‐8 is a major bioactive segment of CCK that retains most of the biological activities of CCK
  • 靶點(diǎn): Cholecystokinin Receptor;Apoptosis;PI3KAkt
  • 體內(nèi)研究:
    Sincalide (Cholecystokinin octapeptide, CCK‐8) (i.p.; 50 μg/kg/d; for 4 weeks) alleviates fibrosis in the noninfarcted regions and delay the left ventricular remodeling and the progress of heart failure in a MI rat model
  • 參考文獻(xiàn):
    1. Maher KA et al. Kinevac (sincalide for injection)/Squibb Diagnostics. Gastroenterol Nurs. 1991 Oct;14(2):98-100. 2. Ziessman HA. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues. J Nucl Med Technol. 2019 Sep;47(3):210-212. 3. Can Wang, et al. Protective effect of cholecystokinin octapeptide on angiotensin II-induced apoptosis in H9c2 cardiomyoblast cells. J Cell Biochem. 2020 Jul;121(7):3560-3569. 4. Can Wang, et al. Cholecystokinin octapeptide reduces myocardial fibrosis and improves cardiac remodeling in post myocardial infarction rats. Int J Biochem Cell Biol. 2020 Aug;125:105793.
  • 溶解性: DMF  :  50  mg/mL  (43.73  mM;  Need  ultrasonic)    H2O  :  0.1  mg/mL  (0.09  mM;  Need  ultrasonic  and  warming)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 0.875 ml 4.373 ml 8.747 ml
    5 mM 0.175 ml 0.875 ml 1.749 ml
    10 mM 0.087 ml 0.437 ml 0.875 ml
    50 mM 0.017 ml 0.087 ml 0.175 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。